P21 for GLP-1 Cognitive Fog in Pediatric Obesity
P21, a cerebrolysin-derived peptide, is being explored for GLP-1-induced cognitive fog in pediatric obesity. This article reviews its mechanism, an...
Read More →All Articles
Explore our complete collection of peptide guides, research, and wellness insights
Semax as a Nootropic Countermeasure for GLP-1-Induced Cognitive Fog
Semax and P21 are peptide nootropics often floated as fixes for GLP-1 cognitive fog. This article separates the real evidence from the hype, with a...
Read More →Semax and P21 as Neuroprotective Adjuncts for GLP-1 Users
GLP-1 receptor agonists have changed the landscape of metabolic medicine, but a subset of users reports cognitive side effects that blunt the benef...
Read More →Semax and P21 for Cognitive Support During GLP-1-Induced Alcohol Craving Reduction
GLP-1 receptor agonists like semaglutide and tirzepatide have shifted from metabolic treatments to unexpected allies in alcohol use disorder. Clinical
Read More →Semax for GLP-1 Users Facing Cognitive Fatigue from Alcohol Craving Reduction
GLP-1 receptor agonists have changed the landscape for alcohol use disorder, but the cognitive cost of reduced cravings is rarely discussed. As
Read More →P21 Neuroprotection Against Alcohol-Induced Cognitive Decline in the VA's GLP-1 Trial Population
Veterans with alcohol use disorder often face a double threat: metabolic dysfunction and lasting cognitive impairment. The VA's exploration of GLP-1
Read More →P21 for Cognitive Recovery in Veterans with Alcohol Use Disorder
P21, a synthetic peptide, shows preclinical promise for reversing alcohol-related cognitive deficits in veterans. This article reviews the research...
Read More →Semax & P21 Synergy for Post-Concussion Rehab: FDA Review Impact
Post-concussion cognitive deficits often linger for months, disrupting working memory, processing speed, and emotional regulation. Two synthetic
Read More →